Immunogenic cell death and DAMPs in cancer therapy DV Krysko, AD Garg, A Kaczmarek, O Krysko, P Agostinis, ... Nature reviews cancer 12 (12), 860-875, 2012 | 2580 | 2012 |
Necroptosis: the release of damage-associated molecular patterns and its physiological relevance A Kaczmarek, P Vandenabeele, DV Krysko Immunity 38 (2), 209-223, 2013 | 1511 | 2013 |
Apoptosis and necrosis: detection, discrimination and phagocytosis DV Krysko, TV Berghe, K D’Herde, P Vandenabeele Methods 44 (3), 205-221, 2008 | 958 | 2008 |
Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion JP Friedmann Angeli, DV Krysko, M Conrad Nature Reviews Cancer 19 (7), 405-414, 2019 | 926 | 2019 |
Consensus guidelines for the detection of immunogenic cell death O Kepp, L Senovilla, I Vitale, E Vacchelli, S Adjemian, P Agostinis, ... Oncoimmunology 3 (9), e955691, 2014 | 852 | 2014 |
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death AD Garg, DV Krysko, T Verfaillie, A Kaczmarek, GB Ferreira, T Marysael, ... The EMBO journal 31 (5), 1062-1079, 2012 | 841 | 2012 |
Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation DV Krysko, P Agostinis, O Krysko, AD Garg, C Bachert, BN Lambrecht, ... Trends in immunology 32 (4), 157-164, 2011 | 779 | 2011 |
Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation AD Garg, D Nowis, J Golab, P Vandenabeele, DV Krysko, P Agostinis Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1805 (1), 53-71, 2010 | 620 | 2010 |
Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma B Hassannia, B Wiernicki, I Ingold, F Qu, S Van Herck, YY Tyurina, ... The Journal of clinical investigation 128 (8), 3341-3355, 2018 | 509 | 2018 |
Molecular mechanisms and pathophysiology of necrotic cell death N Vanlangenakker, TV Berghe, DV Krysko, N Festjens, P Vandenabeele Current molecular medicine 8 (3), 207-220, 2008 | 483 | 2008 |
ER stress-induced inflammation: does it aid or impede disease progression? AD Garg, A Kaczmarek, O Krysko, P Vandenabeele, DV Krysko, ... Trends in molecular medicine 18 (10), 589-598, 2012 | 461 | 2012 |
Clearance of apoptotic and necrotic cells and its immunological consequences DV Krysko, K D’Herde, P Vandenabeele Apoptosis 11 (10), 1709-1726, 2006 | 417 | 2006 |
Vaccination with necroptotic cancer cells induces efficient anti-tumor immunity TL Aaes, A Kaczmarek, T Delvaeye, B De Craene, S De Koker, ... Cell reports 15 (2), 274-287, 2016 | 410 | 2016 |
Molecular and translational classifications of DAMPs in immunogenic cell death AD Garg, L Galluzzi, L Apetoh, T Baert, RB Birge, JM Bravo-San Pedro, ... Frontiers in immunology 6, 588, 2015 | 404 | 2015 |
Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future R Alzeibak, TA Mishchenko, NY Shilyagina, IV Balalaeva, MV Vedunova, ... Journal for immunotherapy of cancer 9 (1), 2021 | 355 | 2021 |
Hypericin-based photodynamic therapy induces surface exposure of damage-associated molecular patterns like HSP70 and calreticulin AD Garg, DV Krysko, P Vandenabeele, P Agostinis Cancer Immunology, Immunotherapy 61, 215-221, 2012 | 330 | 2012 |
Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity I Efimova, E Catanzaro, L Van der Meeren, VD Turubanova, H Hammad, ... Journal for immunotherapy of cancer 8 (2), 2020 | 316 | 2020 |
ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death AD Garg, AM Dudek, GB Ferreira, T Verfaillie, P Vandenabeele, ... Autophagy 9 (9), 1292-1307, 2013 | 310 | 2013 |
Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production G Brouckaert, M Kalai, DV Krysko, X Saelens, D Vercammen, M Ndlovu, ... Molecular biology of the cell 15 (3), 1089-1100, 2004 | 301 | 2004 |
Determination of apoptotic and necrotic cell death in vitro and in vivo TV Berghe, S Grootjans, V Goossens, Y Dondelinger, DV Krysko, ... Methods 61 (2), 117-129, 2013 | 292 | 2013 |